Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Introduction: Recent developments in diagnostic technology can support earlier, more accurate diagnosis of non‐Alzheimer's disease (AD) dementias. Methods: To evaluate potential economic benefits of early rule‐out of AD, annual medical resource use and costs for Medicare beneficiaries potentially misdiagnosed with AD prior to their diagnosis of vascular dementia (VD) or Parkinson's disease (PD) were compared with that of similar patients never diagnosed with AD. Results: Patients with prior AD diagnosis used substantially more medical services every year until their VD/PD diagnosis, resulting in incremental annual medical costs of approximately $9,500‐$14,000. However, following their corrected diagnosis, medical costs converged with those of patients never diagnosed with AD. Discussion: The observed correlation between timing of correct diagnosis and subsequent reversal in excess costs is strongly suggestive of the role of misdiagnosis of AD ‐ rather than AD comorbidity ‐ in this patient population. Our findings suggest potential benefits from earlier, accurate diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242 · cited 1×
“The two groups were then matched 1:1 using a propensity score-based “greedy” matching method [20,21].”
MethodPrevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Beach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b211b · Cited by 1,103 · cited 1×
“The application of neuropathologic and neuroimaging techniques has revealed a substantial rate of misdiagnosis for multiple types of dementia in both clinical and research settings, even when using strict diagnostic criteria [10–12].”
Overlap between neurodegenerative disorders
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00605.x · Cited by 146 · cited 1×
“The diagnosis and management of patients with dementing illnesses can be challenging and uncertain as the underlying causes can present clinically in ways that mask their true natures or reflect the impact of confounding comorbid conditions [7].”
BackgroundGaugler, J. E., Ascher-Svanum, H., Roth, D. L., Fafowora, T., Siderowf, A., & Beach, T. G. (2013) · BMC Geriatrics · doi:10.1186/1471-2318-13-137 · Cited by 97 · cited 1×
“For example, a recent study analyzed data from the NACC Uniform Data Set along with the corresponding NACC neuropathologic data and found that 18%–67% of the patients who were misdiagnosed with AD received medications that were potentially inappropriate [17].”
MethodPre-Diagnosis Excess Acute Care Costs in Alzheimer’s Patients among a US Medicaid Population
Geldmacher, D. S., Kirson, N. Y., Birnbaum, H. G., Eapen, S., Kantor, E., Cummings, A. K., & Joish, V. N. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0038-9 · Cited by 53 · cited 1×
“At the same time, previous studies have shown that early diagnosis and treatment for AD can potentially delay institutionalization among these patients and result in substantial cost savings for payers [15,16].”
ResultSelf-citation
Cited by
Biomarkers for neurodegenerative diseases
Hansson, O. (2021) · Nature Medicine · doi:10.1038/s41591-021-01382-x · Cited by 1,159
Spectral-Domain OCT Measurements in Alzheimer’s Disease
Chan, V. T. T., Sun, Z., Tang, S., Chen, L. J., Wong, A., Tham, C. C., Wong, T. Y., Chen, C., Ikram, M. K., Whitson, H. E., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.08.009 · Cited by 360
El-Hayek, Y. H., Wiley, R. E., Khoury, C. P., Daya, R. P., Ballard, C., Evans, A. R., Karran, M., Molinuevo, J. L., Norton, M., & Atri, A. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-190426 · Cited by 216
Dwibedi, N., Findley, P. A., Wiener R, C., Shen, C., & Sambamoorthi, U. (2018) · Medical Care · doi:10.1097/mlr.0000000000000869 · Cited by 39
Metadata
- Authors
- Hunter, C. A., Kirson, N. Y., Desai, U., Cummings, A. K. G., Faries, D. E., & Birnbaum, H. G.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2015-07-20
- Volume
- 11
- Issue
- 8
- Pages
- 887-895
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W1961763941
- Cited by
- 58
- References
- 7
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries. https://app.cochat.ai/papers/10.1016/j.jalz.2015.06.1889
- The paper
- Hunter, C. A., Kirson, N. Y., Desai, U., Cummings, A. K. G., Faries, D. E., & Birnbaum, H. G. (2015). Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2015.06.1889
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.